Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Terikalant and barium decrease the area of vulnerability to ventricular fibrillation induction by T-wave shocks.

Xiangqian Qi1, Pryam Varma, David Newman

  • 1Division of Cardiology, Department of Medicine, St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada.

Journal of Cardiovascular Pharmacology
|January 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human-Centered Multi-Sensor Framework for Identifying Driving Patterns Associated with Cognitive Decline Through Quantitative Analysis.

Research square·2026
Same author

Radioguided occult lesion localisation for wide local excision, excision biopsies and in combination with radioisotope sentinel lymph node localisation (SNOLL) - 10 year experience of a single centre.

Surgery in practice and science·2026
Same author

Machine Learning-Driven Nanopore Sensing for Quantitative, Label-Free miRNA Detection.

Small methods·2026
Same author

Sensor-Detected Differences in Behaviors of Older Drivers with Pre-MCI and Mild Cognitive Impairment vs. Unimpaired Drivers.

Sensors (Basel, Switzerland)·2026
Same author

Enhancing road safety: In-vehicle sensor analysis of cognitive impairment in older drivers.

Multimedia tools and applications·2025
Same author

Quad-tree Based Driver Classification using Deep Learning for Mild Cognitive Impairment Detection.

IEEE access : practical innovations, open solutions·2025
Same journal

Integration of Mendelian Randomization and FAERS Database Analysis Reveals the Association Between Ergotamine and Aortic and Mitral Valve Diseases.

Journal of cardiovascular pharmacology·2026
Same journal

A Comprehensive Review of PCSK9 Inhibitor Therapy.

Journal of cardiovascular pharmacology·2026
Same journal

SGLT2 Inhibitors and Progression of Chronic Kidney Disease in Patients with Elevated Lipoprotein(a): A Real-World Cohort Study.

Journal of cardiovascular pharmacology·2026
Same journal

Aspirin in primary prevention: a case for selective use.

Journal of cardiovascular pharmacology·2026
Same journal

GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease Treatment.

Journal of cardiovascular pharmacology·2026
Same journal

Expert Opinion: Restrictions, Precautions, or Normalcy? Defining Everyday Risk in Patients Treated With IL-1 Blockers for Recurrent Pericarditis.

Journal of cardiovascular pharmacology·2026
See all related articles

Potassium channel blockers, like terikalant and barium, reduce the area of vulnerability (AOV) to ventricular fibrillation (VF) induction. This finding suggests a link between these blockers and anti-arrhythmic drug efficacy.

Area of Science:

  • Cardiovascular Physiology
  • Electrophysiology
  • Pharmacology

Background:

  • The area of vulnerability (AOV) is a proposed metric for assessing susceptibility to ventricular fibrillation (VF) induction via electrical shocks.
  • Understanding factors that influence VF vulnerability is crucial for developing effective anti-arrhythmic strategies.

Purpose of the Study:

  • To investigate the effects of potassium channel blockers, terikalant and barium, on the area of vulnerability (AOV) to ventricular fibrillation (VF) induction.
  • To determine the impact of these agents on the upper limit of vulnerability (ULV), defibrillation threshold (DFT), and ventricular vulnerability period (VVP).

Main Methods:

  • Biphasic shocks were delivered to dogs at varying voltages before and after administration of terikalant or barium.
  • Measurements included AOV, ULV, DFT, and VVP.

Related Experiment Videos

  • A control group received a vehicle instead of the active agents.

    • Main Results:

    • Both terikalant and barium significantly decreased the AOV (34% and 28%, respectively).
    • Terikalant reduced ULV, DFT, and VVP, while barium decreased ULV and DFT.
    • ULV demonstrated a strong correlation with DFT following both drug treatments.

    Conclusions:

    • Potassium channel blockers reduce the susceptibility to VF induction, potentially through mechanisms related to decreased DFT.
    • These findings support the role of potassium channel blockade in the anti-arrhythmic actions of Class III drugs.
    • The study highlights the therapeutic potential of targeting potassium channels for managing cardiac arrhythmias.